85 FR 33 pg. 9473 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DD15-0030601SUPP20, Using Longitudinal Data To Characterize the Natural History of Fragile X Syndrome To Improve Service; Amended Notice of Meeting
Type: NOTICEVolume: 85Number: 33Page: 9473
Page: 9473FR document: [FR Doc. 2020-03166 Filed 2-18-20; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DD15-0030601SUPP20, Using Longitudinal Data To Characterize the Natural History of Fragile X Syndrome To Improve Service; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DD15-0030601SUPP20, Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Service; April 2, 2020; 11 a.m.-5 p.m., (EDT). Teleconference, which was published in the Federal Register on Monday, February 3, 2020, Volume 85, Number 22, pages 5963-5964.
The meeting is being amended to change the title of the meeting to DD15-003, Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Service. The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-03166 Filed 2-18-20; 8:45 am]
BILLING CODE 4163-18-P